1. AB0226 Decline in anti-ccp and rheumatoid factor levels in patients with early rheumatoid arthritis after 2 years of treatment with intensive combination strategies, including prednisolone: the cobra-light trial. (12th June 2018) Authors: Folmo, H.D.; ter Wee, M.M.; den Uyl, D.; Konijn, N.P.; Kerstens, P.J.; Voskuyl, A.E.; van Schaardenburg, D.; Nurmohamed, M.T.; Boers, M.; Lems, W.F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗